RepliCel Life Sciences Inc (OTCQB:REPCF)

0.2784
Delayed Data
As of Jun 22
 +0.0213 / +8.29%
Today’s Change
0.25
Today|||52-Week Range
0.55
-10.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization772.71828.16818.07592.19
 
 
 
 
 
 
Operating ExpensesGross Income-772.71-828.16-818.07-592.19
 
 
 
 
 
General Expenses1.9M968.2K459.4K383.9K
 
 
 
 
 
Research And Development996.8K635.8K62.9K45.9K
 
 
 
 
 
Total Operating Expenses1.9M969.0K460.2K384.5K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.9M-969.0K-460.2K-384.5K
 
 
 
 
 
Other Expenses-4.4K19.3K-27.2K-4.9K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.9M-948.6K-487.0K-389.4K
 
 
 
 
 
Net Income-1.9M-948.6K-487.0K-389.4K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.6M18.6M21.4M16.7M
 
 
 
 
 
Shares To Calculate EPS Diluted18.6M18.6M21.4M16.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.10-$0.05-$0.02-$0.02
 
 
 
 
 
EPS Diluted-$0.10-$0.05-$0.02-$0.02